{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.196.12.1402","meta":{"source":"https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.464.1003.196.12.1402/expansion"},"url":"http://vsac.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1402","version":"eCQM Update 2020-05-07","name":"Butabarbital","title":"Butabarbital","status":"active","date":"2017-05-04","description":"(Clinical Focus: This value set contains concepts that represent butabarbital medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; butabarbital only.),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; butabarbital in combination with other medications.)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"2020-01","concept":[{"code":"1047805","display":"butabarbital 15 MG / Hyoscyamine hydrobromide 0.3 MG / Phenazopyridine hydrochloride 150 MG Oral Tablet"},{"code":"1251600","display":"Butabarbital sodium 100 MG Oral Tablet"},{"code":"1251610","display":"Butabarbital sodium 15 MG Oral Tablet"},{"code":"1251614","display":"Butabarbital sodium 30 MG Oral Tablet"},{"code":"1251625","display":"Butabarbital sodium 6 MG/ML Oral Solution"}]}]}}